We have previously shown that ASPM augments canonical Wnt signaling by positively regulating critical upstream Wnt mediators, including Dvl proteins and β‐catenin, in PDAC and prostate cancer cells 11, 22. The gene discussed is ASPM; the disease is prostate carcinoma.